Sickle cell specialist named director of genetic medicine at Johns Hopkins

February 13, 2022

1 minute read

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Ambroise Wonkam, MD, PhD, DMedSc, was appointed director of the Department of Genetic Medicine at Johns Hopkins Medicine.

Wonkam will also serve as director of the McKusick-Nathans Institute for Genetic Medicine.

Wonkam, a world-renowned geneticist who grew up in Cameroon, is renowned for his expertise in sickle cell disease.

Ambroise Wonkam, MD, PhD, DMedSc

Ambroise Wonkam

“To make genetic medicine a global good for understanding the variability between us, we need to understand our genome to the fullest,” Wonkam said in a press release. “We have a duty to continue this work and to make innovations in genetic medicine sustainable and equitable for all populations.

Wonkam previously served as Professor of Medical Genetics, Associate Dean of Research and Director of African Population Genetic Medicine at the University of Cape Town.

His research has explored the psychosocial aspects of sickle cell disease and the genetic links to the symptoms of the disease.

He recently established the Sickle Africa Data Coordinating Center to study how epidemiological, clinical and genetic information from African populations with sickle cell disease can be correlated with treatment outcomes.

“We are delighted to welcome Dr. Wonkam as a departmental leader in our medical school,” Paul B. Rothman, MD, dean of the medical school and CEO of Johns Hopkins Medicine, said in a press release. “He brings to Hopkins a diverse and extensive body of research and clinical experience that will serve as the foundation for our institution’s continued leadership and innovation in the field of genetic medicine.

Wonkam succeeds David Vallee, MD, which will remain on the Johns Hopkins faculty and continue its clinical and research functions.

Comments are closed.